獲獎紀錄

1. 2024年臺北市醫師公會青年杏林獎
2. 2024年臺北榮民總醫院住院醫師杏林獎第一名
3. 2021年亞太神經學年會論文口頭報告銀獎

Peer-reviewed articles (Old to new)

1. Ling YH, Chen SP, Fann CS, Wang SJ, Wang YF. TRPM8 genetic variant is associated with chronic migraine and allodynia. J Headache Pain. 2019 Dec. 20(1):115
2. Cho S^#, Ling YH^#, Lee MJ, Chen SP, Fuh JL, Lirng JF, Cha J, Wang YF, Wang SJ, Chung CS. Temporal profile of blood-brain barrier breakdown in reversible cerebral vasoconstriction syndrome. Stroke. 2020 May. 51(5):1451-7 (co-first author)
3. Pan LLH, Wang YF, Lai KL, Chen WT, Chen SP, Ling YH, Chou LW, Treede RD, Wang SJ. Mechanical punctate pain threshold is associated with headache frequency and phase in patients with migraine. Cephalalgia. 2020 Aug. 40(9):990-997
4. Ling YH, Chen SP. Narrative review: headaches after reversible cerebral vasoconstriction syndrome. Curr Pain Headache Rep. 2020 Dec. 24:1-4
5. Wu CH, Lirng JF, Ling YH, Wang YF, Wu HM, Fuh JL, Lin PC, Wang SJ, Chen SP. Noninvasive characterization of human glymphatics and meningeal lymphatics in an in vivo model of blood–brain barrier leakage. Ann Neurol. 2021 Jan. 89(1):111-24
6. Ling YH, Tai YH, Wu HL, Fu WL, Tsou MY, Chang KY. Evaluating the association of preoperative parecoxib with acute pain trajectories after video-assisted thoracoscopic surgery: a single-centre cohort study in Taiwan. BMJ open. 2021 Feb. 11(2):e038985
7. Wu CH, Lirng JF, Wu HM, Ling YH, Wang YF, Fuh JL, Lin CJ, Ling K, Wang SJ, Chen SP. Blood-brain barrier permeability in patients with reversible cerebral vasoconstriction syndrome assessed with dynamic contrast-enhanced MRI. Neurology. 2021 Nov. e1847-59
8. Ling YH, Wang YF, Lirng JF, Fuh JL, Wang SJ, Chen SP. Post-reversible cerebral vasoconstriction syndrome headache. J Headache Pain. 2021 Dec. 22(1):1-8
9. Lin PT, Wang YF, Fuh JL, Lirng JF, Ling YH, Chen SP, Wang SJ. Diagnosis and classification of headache associated with sexual activity using a composite algorithm: A cohort study. Cephalalgia. 2021 Dec. 41(14):1447-57
10. Tu YH, Wang YF, Yuan H, Chen SP, Tzeng YS, Chen WT, Lai KL, Ling YH, Wang SJ. Most bothersome symptoms in patients with migraine: A hospital‐based study in Taiwan. Headache. 2022 May. 62(5):596-603
11. Pan LLH, Wang YF, Ling YH, Lai KL, Chen SP, Chen WT, Treede RD, Wang SJ. Pain sensitivities predict prophylactic treatment outcomes of flunarizine in chronic migraine patients: A prospective study. Cephalalgia. 2022 Aug. 42(9):899-909
12. Chiang YK, Ling YH, Chang FC, Fuh JL. A clinical study of artery of Percheron infarction. J Chin Med Assoc. 2022 Nov. 85(11):1098-100.
13. Wang YF, Tzeng YS, Yu CC, Ling YH, Chen SP, Lai KL, Wang SJ. Clinical Utility of Leeds Dependence Questionnaire in Medication-Overuse Headache. Diagnostics. 2023 Jan. 13(3):472
14. Lange KS^*, Choi SY^*, Ling YH, Chen SP, Mawet J, Duflos C, Lee MJ, Ducros A, Wang SJ^#, Pezzini A^#. Reversible cerebral Vasoconstriction syndrome intERnational CollaborativE (REVERCE) network: Study protocol and rationale of a multicentre research collaboration. Eur Stroke J. 2023 Jun. 23969873231182200
15. Wu CH, Kuo Y, Chang FC, Lirng JF, Ling YH, Wang YF, Wu HM, Fuh JL, Lin CJ, Wang SJ, Chen SP. Noninvasive investigations of human glymphatic dynamics in a diseased model. Eur Radiol. 2023 Jul.
16. Ling YH, Chi NF, Pan LLH, Wang YF, Wu CH, Lirng JF, Fuh JL, Wang SJ, Chen SP. Association between impaired dynamic cerebral autoregulation and BBB disruption in reversible cerebral vasoconstriction syndrome. J Headache Pain. 2023 Dec. 24(1):170
17. Wu CH, Kuo Y, Ling YH, Wang YF, Fuh JL, Lirng JF, Wu HM, Wang SJ, Chen SP. Dynamic changes in glymphatic function in reversible cerebral vasoconstriction syndrome. J Headache Pain. 2024 Feb. 25(1):17